Terapia trombolítica en TEP submasivo/riesgo intermedio: Evidencias y sugerencias post estudio Pulmonary Embolism Thrombolysis (PEITHO)
Therapy for submassive pulmonary embolism (intermediate risk), remains controversial. New evidence has appeared that may help us in the process of decision making. We review the relevant literature, outline prognostic factors, and discuss current recommendations and controversies regarding the available alternatives such as systemic and catheter-directed thrombolytic use.
Saved in:
Main Authors: | Marín V,Arnaldo, Gazmuri B,José Tomás, Andresen V,Max, Andresen,Max |
---|---|
Format: | Digital revista |
Language: | Spanish / Castilian |
Published: |
Sociedad Médica de Santiago
2015
|
Online Access: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872015000700011 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thrombolysis in acute pulmonary embolism
by: Bottega,Tiago Spiazzi, et al.
Published: (2020) -
Controversial and future role of thrombolysis and endovascular therapies in submassive pulmonary embolism
by: Porres-Aguilar,Mateo, et al.
Published: (2014) -
Persuasion in Greek tragedy : a study of Peitho /
by: Buxton, R.G.A. 16746
Published: (1982) -
Terapêutica trombolítica em trombose de prótese valvar
by: Katz,Marcelo, et al.
Published: (2005) -
Pulmonary cement embolism
by: Ribeiro Neto,Manuel Lessa, et al.
Published: (2015)